The award was presented by Shriram Nene and Jithendra Kumar, who cited Prasad’s interdisciplinary research that merges computational biology, artificial intelligence and biomedical science, with a particular emphasis on cancer diagnostics and drug discovery.
According to the summit’s press release, Prasad’s work spans AI/ML and quantum‑computing applications in cancer biology, molecular medicine and therapeutic development, positioning him at the forefront of data‑driven biomedical innovation.
His professional distinctions include serving as Ambassador for the European Association for Cancer Research since 2019, being elected Fellow of the Linnean Society of London in 2022, and holding memberships in the Royal Society of Biology (2022) and the Royal Society of Chemistry (2024).
Beyond the medal, Prasad will act as Organising Secretary for the CSIR‑sponsored International Conference on “AI‑Driven Drug Discovery: Bridging Data, Molecules, and Medicine” (ICAIDD‑2026), slated to take place at JSS AHER, Mysuru, from 15 to 17 October 2026.
The upcoming conference aims to convene researchers and industry experts to explore how artificial‑intelligence techniques can accelerate drug discovery pipelines, echoing the interdisciplinary approach that earned Prasad the Kalam Medal.